Publikationen

Prieto-Garcia C, Hartmann O, Reissland M, Fischer T, Maier CR, Rosenfeldt M, Schülein-Völk C, Klann K, Kalb R, Dikic I, Münch C, Diefenbacher ME (2022)
Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway.
Cell Death Differ 29 3 S.568-584
DOI: 10.1038/s41418-021-00875-z

Breidenbach C, Ansmann L, Sibert NT, Wesselmann S, Dieng S, Carl EG, Feick G, Stoklossa C, Taubert A, Pomery A, Beyer B, Blana A, Brock M, Distler F, Enge M, Gaber AA, Gilfrich C, Hinkel A, Kaftan B, Knoll T, Kunath F, Oostdam SJ, Peters I, Polat B, Schrodi V, Zengerling F, Kowalski C (2022)
Predictors for the utilization of social service counseling by prostate cancer patients.
Support Care Cancer 30 3 S.2327-2339
DOI: 10.1007/s00520-021-06620-z

Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgäuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Sülberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Rödel C, German Rectal Cancer Study Group (2022)
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
JAMA Oncol 8 1
DOI: 10.1001/jamaoncol.2021.5445

Johannsen M, Stoll C, Raida M, van Oorschot B, Flörcken A (2022)
Supportive therapy and complementary medicine in renal cell carcinoma.
World J Urol 40 10 S.2359-2371
DOI: 10.1007/s00345-021-03885-1

Kuon J, Blasi M, Unsöld L, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, Stahlhut K, Heider A, Lordick F, Thomas M, Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG) (2022)
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study.
Support Care Cancer 30 4 S.3131-3140
DOI: 10.1007/s00520-021-06736-2

Roch C, Kress T, Erlenwein J, Meissner W, Brede EM, van Oorschot B (2022)
Applicability of QUIKS in conservatively treated tumor inpatients.
Schmerz 36 5 S.342-349
DOI: 10.1007/s00482-021-00599-6

Klement RJ, Popp I, Kaul D, Ehret F, Grosu AL, Polat B, Sweeney RA, Lewitzki V (2022)
"Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis."
J Neurooncol 156 2 S.407-417 DOI: 10.1007/s11060-021-03926-0

Fischer T, Hartmann O, Reissland M, Prieto-Garcia C, Klann K, Pahor N, Schülein-Völk C, Baluapuri A, Polat B, Abazari A, Gerhard-Hartmann E, Kopp HG, Essmann F, Rosenfeldt M, Münch C, Flentje M, Diefenbacher ME (2022)
PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy.
Cell Biosci 12 1
DOI: 10.1186/s13578-022-00778-7

Brosch PK, Korsa T, Taban D, Eiring P, Hildebrand S, Neubauer J, Zimmermann H, Sauer M, Shirakashi R, Djuzenova CS, Sisario D, Sukhorukov VL (2022)
Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
Cancers (Basel) 14 23
DOI: 10.3390/cancers14235794

Lisowski D, Trömel J, Lutyj P, Lewitzki V, Hartrampf PE, Polat B, Flentje M, Tamihardja J (2022)
Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma.
Sci Rep 12 1
DOI: 10.1038/s41598-022-24192-8

Kraft J, Weick S, Breuer K, Lutyj P, Bratengeier K, Exner F, Richter A, Tamihardja J, Lisowski D, Polat B, Flentje M (2022)
Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms.
Radiat Oncol 17 1
DOI: 10.1186/s13014-022-02156-6

Diefenhardt M, Martin D, Ludmir EB, Fleischmann M, Hofheinz RD, Ghadimi M, Kosmala R, Polat B, Friede T, Minsky BD, Rödel C, Fokas E (2022)
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.
Cancers (Basel) 14 18
DOI: 10.3390/cancers14184425

Zimmermann M, Richter A, Weick S, Exner F, Mantel F, Diefenhardt M, Fokas E, Kosmala R, Flentje M, Polat B (2022)
Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center.
Sci Rep 12 1
DOI: 10.1038/s41598-022-25647-8

Polat B, Wohlleben G, Kosmala R, Lisowski D, Mantel F, Lewitzki V, Löhr M, Blum R, Herud P, Flentje M, Monoranu CM (2022)
Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma.
Cancer Cell Int 22 1
DOI: 10.1186/s12935-022-02510-4

Tamihardja J, Zehner L, Hartrampf PE, Cirsi S, Wegener S, Buck AK, Flentje M, Polat B (2022)
Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era.
Cancers (Basel) 14 19
DOI: 10.3390/cancers14194956

Tamihardja J, Zehner L, Hartrampf P, Lisowski D, Kneitz S, Cirsi S, Razinskas G, Flentje M, Polat B (2022)
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up.
Cancers (Basel) 14 15
DOI: 10.3390/cancers14153766

Tamihardja J, Lawrenz I, Lutyj P, Weick S, Guckenberger M, Polat B, Flentje M (2022)
"Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer."
Strahlenther Onkol 198 8 S.735-743 DOI: 10.1007/s00066-022-01953-y

Tamihardja J, Weick S, Lutyj P, Zimmermann M, Bratengeier K, Flentje M, Polat B (2022)
Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer.
Acta Oncol 61 6 S.714-719
DOI: 10.1080/0284186X.2022.2068968

Wegener S, Schindhelm R, Sauer OA (2022)
Implementing corrections of isocentric shifts for the stereotactic irradiation of cerebral targets: Clinical validation.
J Appl Clin Med Phys 23 5
DOI: 10.1002/acm2.13577

Lechner W, Alfonso R, Arib M, Huq MS, Ismail A, Kinhikar R, Lárraga-Gutiérrez JM, Mani KR, Maphumulo N, Sauer OA, Shoeir S, Suriyapee S, Christaki K (2022)
A multi-institutional evaluation of small field output factor determination following the recommendations of IAEA/AAPM TRS-483.
Med Phys 49 8 S.5537-5550
DOI: 10.1002/mp.15797

Beck M, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen DR, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Hayoz S, Schär C, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti DG, Reuter C, Gomez S, Khanfir K, Aebersold DM, Ghadjar P, Pra AD (2022)
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Int J Radiat Oncol Biol Phys 113 1 S.80-91
DOI: 10.1016/j.ijrobp.2021.12.174

Müller AC, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Niehoff P, Pinkawa M, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) (2022)
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Strahlenther Onkol 198 8 S.683-689
DOI: 10.1007/s00066-022-01961-y

Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Weber DC, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Obrecht D, Rutkowski S, Timmermann B, Kortmann RD (2022)
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
Strahlenther Onkol 198 3 S.282-290
DOI: 10.1007/s00066-021-01822-0

Oubaid N, Ullrich A, Schwenzitzki L, Berendt J, Heckel M, Hentschel L, Hornemann B, Jentschke E, Pauli B, Simon ST, Stiel S, van Oorschot B, Oechsle K (2022)
German measurements for family caregiver need assessment A narrative review on available self-assessments measuring different dimensions of family caregiver needs.
Onkologe 28 5 S.420-428
DOI: 10.1007/s00761-022-01131-w

Schallenburger M, Reuters MC, Schwartz J, Fischer M, Roch C, Werner L, Bausewein C, Simon ST, van Oorschot B, Neukirchen M (2022)
Inpatient generalist palliative care during the SARS-CoV-2 pandemic - experiences, challenges and potential solutions from the perspective of health care workers.
BMC Palliat Care 21 1
DOI: 10.1186/s12904-022-00958-9

Bausewein C, Hodiamont F, Berges N, Ullrich A, Gerlach C, Oechsle K, Pauli B, Weber J, Stiel S, Schneider N, Krumm N, Rolke R, Gebel C, Jansky M, Nauck F, Wedding U, van Oorschot B, Roch C, Werner L, Fischer M, Schallenburger M, Reuters MC, Schwartz J, Neukirchen M, Gülay A, Maus K, Jaspers B, Radbruch L, Heckel M, Klinger I, Ostgathe C, Kriesen U, Junghanß C, Lehmann E, Gesell D, Gauder S, Boehlke C, Becker G, Pralong A, Strupp J, Leisse C, Schloesser K, Voltz R, Jung N, Simon ST, PallPan Study Group (2022)
National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
BMC Palliat Care 21 1
DOI: 10.1186/s12904-021-00898-w

Werner L, Fischer M, van Oorschot B, Ziegaus A, Schwartz J, Reuters MC, Schallenburger M, Henking T, Neuderth S, Simon S, Bausewein C, Roch C, Neukirchen M, für die PallPan-Forschungsgruppe (2022)
Generalist palliative care in hospitals during the first wave of the COVID-19 pandemic.
Dtsch Med Wochenschr 147 21 S.e102-e113
DOI: 10.1055/a-1918-6407

Pollmann S, Toussaint A, Flentje M, Wegener S, Lewitzki V (2022)
Dosimetric Evaluation of Commercially Available Flat vs. Self-Produced 3D-Conformal Silicone Boluses for the Head and Neck Region.
Front Oncol 12
DOI: 10.3389/fonc.2022.881439

van Oorschot B, Pigorsch S, Werner L, Roch C, Mueller E, Alt-Epping B, Letsch A (2022)
From the "early" to "timely" integration of palliative care in the treatment of oncology patients.
Onkologie 28 11 S.964-973
DOI: 10.1007/s00761-022-01239-z

Razinskas G, Stumm T, Kosmala R, Polat B, Löhr M, Flentje M, Bratengeier K (2022)
The role of beam density and arrangement in non-coplanar IMRT exemplified by the irradiation of brain tumors - Parallels to computed tomographic imaging.
Phys Med 96 S.204-212
DOI: 10.1016/j.ejmp.2021.07.019

Keek SA, Beuque M, Primakov S, Woodruff HC, Chatterjee A, van Timmeren JE, Vallières M, Hendriks LEL, Kraft J, Andratschke N, Braunstein SE, Morin O, Lambin P (2022)
Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics.
Front Oncol 12
DOI: 10.3389/fonc.2022.920393

Kraft J, van Timmeren JE, Frei S, Mayinger M, Borsky K, Kirchner C, Stark LS, Tanadini-Lang S, Wolpert F, Weller M, Woodruff HC, Guckenberger M, Andratschke N (2022)
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective.
Radiother Oncol 172 S.23-31
DOI: 10.1016/j.radonc.2022.04.024

Dal Pra A, Ghadjar P, Hayoz S, Liu VYT, Spratt DE, Thompson DJS, Davicioni E, Huang HC, Zhao X, Liu Y, Schär C, Gut P, Plasswilm L, Hölscher T, Polat B, Hildebrandt G, Müller AC, Pollack A, Thalmann GN, Zwahlen D, Aebersold DM (2022)
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.
Ann Oncol 33 9 S.950-958
DOI: 10.1016/j.annonc.2022.05.007

Tamihardja J, Schortmann M, Lawrenz I, Weick S, Bratengeier K, Flentje M, Guckenberger M, Polat B (2021)
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.
Strahlenther Onkol 197 2 S.124-132 DOI: 10.1007/s00066-020-01678-w

Zetzl T, Renner A, Pittig A, Jentschke E, Roch C, van Oorschot B (2021)
Yoga effectively reduces fatigue and symptoms of depression in patients with different types of cancer.
Support Care Cancer 29 6 S.2973-2982 DOI: 10.1007/s00520-020-05794-2

van Oorschot B, Seufferlein T (2021)
Quality of life vs. treatment intensity vs. side effects in patients with gastrointestinal cancer in the palliative situation
Onkologe 27 4 S.352-360 DOI: 10.1007/s00761-020-00887-3

Wolf F, Sedlmayer F, Aebersold D, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Schmidt-Hegemann NS, Zamboglou C, Zips D, Wiegel T (2021)
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol 197 2 S.89-96 DOI: 10.1007/s00066-020-01723-8

Hummel HD, Kufer P, Gruellich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Doecke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC (2021)
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Immunotherapy 13 2 S.125-141 DOI: 10.2217/imt-2020-0256

Zetzl T, Pittig A, Renner A, van Oorschot B, Jentschke E (2021)
Yoga therapy to reduce fatigue in cancer: effects of reminder e-mails and long-term efficacy.
Support Care Cancer 29 12 S.7725-7735 DOI: 10.1007/s00520-021-06345-z

Heß V, Meng K, Schulte T, Neuderth S, Bengel J, Jentschke E, Zoll M, Faller H, Schuler M (2021)
Unexpressed psychosocial needs in cancer patients at the beginning of inpatient rehabilitation: a qualitative analysis.
J Psychosoc Oncol 39 2 S.173-188 DOI: 10.1080/07347332.2020.1819931

Das IJ, Francescon P, Moran JM, Ahnesjö A, Aspradakis MM, Cheng CW, Ding GX, Fenwick JD, Saiful Huq M, Oldham M, Reft CS, Sauer OA (2021)
Report of AAPM Task Group 155: Megavoltage photon beam dosimetry in small fields and non-equilibrium conditions.
Med Phys 48 10 S.e886-e921 DOI: 10.1002/mp.15030

Djuzenova CS, Fischer T, Katzer A, Sisario D, Korsa T, Steussloff G, Sukhorukov VL, Flentje M (2021)
Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
BMC Cancer 21 1 DOI: 10.1186/s12885-021-08930-1

Guckenberger M, Mantel F, Sweeney RA, Hawkins M, Belderbos J, Ahmed M, Andratschke N, Madani I, Flentje M (2021)
Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
Int J Radiat Oncol Biol Phys 110 2 S.348-357 DOI: 10.1016/j.ijrobp.2020.12.045

Tufman A, Neumann J, Manapov F, Sellmer L, Jung A, Kauffmann-Guerrero D, Kahnert K, Mertsch P, Borgmeier A, Semrau S, Rittmeyer A, Ulm B, Ulm K, Flentje M, Fietkau R, Huber RM (2021)
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
Lung Cancer 160 S.17-27 DOI: 10.1016/j.lungcan.2021.07.008

John C, Dal Bello R, Andratschke N, Guckenberger M, Boda-Heggemann J, Gkika E, Mantel F, Specht HM, Stromberger C, Zehentmayr F, Blanck O, Balermpas P (2021)
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO).
Sci Rep 11 1 DOI: 10.1038/s41598-021-83210-3

Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, Hohenberger W, Arnold D, Hofheinz RD, Ghadimi M, Ströbel P, Staib L, Grabenbauer GG, Folprecht G, Kirste S, Uter W, Gall C, Rödel C, Polat B, of the German Rectal Cancer Study Group (2021)
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
Eur J Cancer 144 S.281-290 DOI: 10.1016/j.ejca.2020.11.029

Cytawa W, Hartrampf P, Lass P, Kircher M, Polat B, Buck AK, Lapa C (2021)
PSMA Theranostics: A "Must Have" in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature.
Clin Genitourin Cancer 19 4 S.e235-e247 DOI: 10.1016/j.clgc.2021.03.008

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM, Swiss Group for Clinical Cancer Research (SAKK) (2021)
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
Eur Urol 80 3 S.306-315 DOI: 10.1016/j.eururo.2021.05.033

Radeloff K, Ramos Tirado M, Haddad D, Breuer K, Müller J, Hochmuth S, Hackenberg S, Scherzad A, Kleinsasser N, Radeloff A (2021)
Superparamagnetic Iron Oxide Particles (VSOPs) Show Genotoxic Effects but No Functional Impact on Human Adipose Tissue-Derived Stromal Cells (ASCs).
Materials 14 2 DOI: 10.3390/ma14020263

Tamihardja J, Cirsi S, Kessler P, Razinskas G, Exner F, Richter A, Polat B, Flentje M (2021)
Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Radiat Oncol 16 1 DOI: 10.1186/s13014-021-01933-z

Jäger A, Wegener S, Sauer OA (2021)
Dose rate correction for a silicon diode detector array.
J Appl Clin Med Phys 22 10 S.144-151 DOI: 10.1002/acm2.13409

Richter A, Wegener S, Breuer K, Razinskas G, Weick S, Exner F, Bratengeier K, Flentje M, Sauer O, Polat B (2021)
Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems.
Radiat Oncol 16 1 DOI: 10.1186/s13014-021-01942-y

Mantel F, Müller E, Kleine P, Zimmermann M, Exner F, Richter A, Weick S, Ströhle S, Polat B, Höcht S, Flentje M (2021)
Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Strahlenther Onkol 197 5 S.405-415 DOI: 10.1007/s00066-021-01756-7

Tamihardja J, Lutyj P, Kraft J, Lisowski D, Weick S, Flentje M, Polat B (2021)
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis.
Front Oncol 11 DOI: 10.3389/fonc.2021.764536

Tamihardja J, Razinskas G, Exner F, Richter A, Kessler P, Weick S, Kraft J, Mantel F, Flentje M, Polat B (2021)
Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms.
J Appl Clin Med Phys 22 9 S.262-270 DOI: 10.1002/acm2.13380

Hannoun-Levi JM, Gal J, Van Limbergen E, Chand ME, Schiappa R, Smanyko V, Kauer-Domer D, Pasquier D, Lemanski C, Racadot S, Houvenaeghel G, Guix B, Belliere-Calandry A, Loessl K, Polat B, Gutierrez C, Galalae R, Polgar C, Strnad V (2021)
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database.
Int J Radiat Oncol Biol Phys 110 2 S.452-461 DOI: 10.1016/j.ijrobp.2020.12.029

Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Walser M, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Rutkowski S, Timmermann B, Kortmann RD (2021)
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Strahlenther Onkol 197 8 S.674-682 DOI: 10.1007/s00066-020-01707-8

Huber RM, Kauffmann-Guerrero D, Hoffmann H, Flentje M (2021)
New developments in locally advanced nonsmall cell lung cancer.
Eur Respir Rev 30 160 DOI: 10.1183/16000617.0227-2020

Hartmann O, Reissland M, Maier CR, Fischer T, Prieto-Garcia C, Baluapuri A, Schwarz J, Schmitz W, Garrido-Rodriguez M, Pahor N, Davies CC, Bassermann F, Orian A, Wolf E, Schulze A, Calzado MA, Rosenfeldt MT, Diefenbacher ME (2021)
Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease.
Front Cell Dev Biol 9 DOI: 10.3389/fcell.2021.641618

Roch C, Heckel M, van Oorschot B, Alt-Epping B, Tewes M (2021)
Screening for Palliative Care Needs: Pilot Data From German Comprehensive Cancer Centers.
JCO Oncol Pract 17 10 S.e1584-e1591 DOI: 10.1200/OP.20.00698

Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F, Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG) (2021)
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.
Oncologist 26 6 S.e1058-e1065 DOI: 10.1002/onco.13751

Schwartz J, Reuters MC, Schallenburger M, Meier S, Roch C, Ziegaus A, Werner L, Fischer M, van Oorschot B, Neukirchen M (2021)
General palliative care during the pandemic.
Onkologe 27 7 S.686-690 DOI: 10.1007/s00761-021-00970-3

Klemmt M, Neuderth S, van Oorschot B, Henking T (2021)
Living wills of residents in nursing homes - which treatment situations and treatment measures are decreed?.
Dtsch Med Wochenschr 146 20 S.e81-e87 DOI: 10.1055/a-1576-6894

Shelan M, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Schmidt-Hegemann NS, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T, Ghadjar P (2021)
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Strahlenther Onkol 197 11 S.993-1000 DOI: 10.1007/s00066-021-01820-2

Roch C, Vogel U, Smol K, Pörner S, van Oorschot B (2021)
Admission of a Terminally Ill Lung Cancer Patient With the Accidental Diagnosis of SARS-CoV-2 to a Palliative Care Unit Resulting in a SARS-CoV-2 Outbreak.
Workplace Health Saf 69 12 S.580-584 DOI: 10.1177/21650799211042518

Hartl V, Rabe A, Jentschke E (2021)
Psycho-oncological methods for patients with advanced cancer-Dignity Therapy
Onkologe 27 9 S.922-928 DOI: 10.1007/s00761-021-00968-x

van Oorschot B (2021)
"SPIKES digital-Breaking bad news during video (family) conferences"
Onkologe 27 12 S.1228-1232 DOI: 10.1007/s00761-021-01053-z

Beck M, Böhmer D, Aebersold DM, Albrecht C, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Sedlmayer F, Zips D, Zschaeck S, Budach V, Wiegel T, Ghadjar P, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) (2020)
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer.
Strahlenther Onkol 196 2 S.109-116 DOI: 10.1007/s00066-019-01553-3

Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone Ii CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D (2020)
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.
Int J Radiat Oncol Biol Phys 107 4 S.631-640 DOI: 10.1016/j.ijrobp.2020.05.012

Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone Ii CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D (2020)
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Radiother Oncol 146 S.223-229 DOI: 10.1016/j.radonc.2020.04.001

Memmel S, Sisario D, Zimmermann H, Sauer M, Sukhorukov VL, Djuzenova CS, Flentje M (2020)
FocAn: automated 3D analysis of DNA repair foci in image stacks acquired by confocal fluorescence microscopy.
BMC Bioinformatics 21 1 DOI: 10.1186/s12859-020-3370-8

Wegener S, Herzog B, Sauer OA (2020)
Detector response in the buildup region of small MV fields.
Med Phys 47 3 S.1327-1339 DOI: 10.1002/mp.1397

Haeger A, Alexander S, Vullings M, Kaiser FMP, Veelken C, Flucke U, Koehl GE, Hirschberg M, Flentje M, Hoffman RM, Geissler EK, Kissler S, Friedl P (2020)
Collective cancer invasion forms an integrin-dependent radioresistant niche.
J Exp Med 217 1 DOI: 10.1084/jem.20181184

Schmid SC, Koll FJ, Rödel C, Maisch P, Sauter A, Beckert F, Seitz A, Kübler H, Flentje M, Chun F, Combs SE, Schiller K, Gschwend JE, Retz M (2020)
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
BMC Cancer 20 1 DOI: 10.1186/s12885-019-6503-6

Richter A, Exner F, Weick S, Lawrenz I, Polat B, Flentje M, Mantel F (2020)
Evaluation of intrafraction prostate motion tracking using the Clarity Autoscan system for safety margin validation.
Z Med Phys 30 2 S.135-141 DOI: 10.1016/j.zemedi.2019.12.004

Klement RJ, Sonke JJ, Allgaeuer M, Andratschke N, Appold S, Belderbos J, Belka C, Dieckmann K, Eich HT, Flentje M, Grills I, Eble M, Hope A, Grosu AL, Semrau S, Sweeney RA, Hoerner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Guckenberger M (2020)
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.
Radiother Oncol 142 S.210-216 DOI: 10.1016/j.radonc.2019.07.008

Roch C, Palzer J, Zetzl T, Störk S, Frantz S, van Oorschot B (2020)
Utility of the integrated palliative care outcome scale (IPOS): a cross-sectional study in hospitalised patients with heart failure.
Eur J Cardiovasc Nurs 19 8 S.702-710 DOI: 10.1177/1474515120919386

Zetzl T, Mann D, Gruner S, Schuler M, Jentschke E, Neuderth S, Roch C, van Oorschot B (2020)
Question prompts to empower cancer patients: results of a randomized controlled trial.
Support Care Cancer 28 6 S.2571-2579 DOI: 10.1007/s00520-019-05036-0

van Oorschot B, Ishii K, Kusomoto Y, Overbeck L, Zetzl T, Roch C, Mettenleiter A, Ozawa H, Flentje M (2020)
Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in Germany and Japan.
J Neural Transm 127 11 S.1481-1489 DOI: 10.1007/s00702-020-02186-y

Roch C, Schendzielorz P, Scherzad A, van Oorschot B, Scheich M (2020)
Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors.
HNO 68 7 S.510-516 DOI: 10.1007/s00106-020-00888-z

Klemmt M, Henking T, Heizmann E, Best L, van Oorschot B, Neuderth S (2020)
Wishes and needs of nursing home residents and their relatives regarding end-of-life decision-making and care planning-A qualitative study.
J Clin Nurs 29 13-14 S.2663-2674 DOI: 10.1111/jocn.15291

Paal P, Brandstötter C, Bükki J, Elsner F, Ersteniuk A, Jentschke E, Stähli A, Slugotska I (2020)
One-week multidisciplinary post-graduate palliative care training: an outcome-based program evaluation.
BMC Med Educ 20 1 S.276 DOI: 10.1186/s12909-020-02200-7

Rabe A, Van Oorschot B, Jentschke E (2020)
Suicidality in cancer patients
Onkologe 26 2 S.163-168 DOI: 10.1007/s00761-020-00712-x

Wack LJ, Exner F, Wegener S, Sauer OA (2020)
The impact of isocentric shifts on delivery accuracy during the irradiation of small cerebral targets-Quantification and possible corrections.
J Appl Clin Med Phys 21 5 S.56-64 DOI: 10.1002/acm2.12854

Zetzl T, Overbeck L, Van Oorschot B (2020)
"Said is not heard, heard is not understood"-assessment of therapeutic goals from the perspective of patients in radiology Experience in daily clinical life and suggestions for patient-physician communication.
Onkologe 26 10 S.951-956 DOI: 10.1007/s00761-020-00812-8

Roch C, van Oorschot B (2020)
Screening hospitalized cancer patients for palliative care needs
Onkologe 26 8 S.752-757 DOI: 10.1007/s00761-020-00791-w

Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Müller AC, Niehoff P, Pinkawa M, Sedlmayer F, Zips D, Wiegel T, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) (2020)
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol 196 7 S.589-597 DOI: 10.1007/s00066-020-01598-9

Hartmann GH, Hensley F, Kapsch RP, Poppe B, Sauer O, Würfel J, Zink K (2020)
Detector Based Determination of Water Absorbed Dose According to DIN 6800 Teil 1: Suggestion for an Extension of the Fundamental Formalism.
Z Med Phys 30 1 S.24-39 DOI: 10.1016/j.zemedi.2019.05.001

Weick S, Breuer K, Richter A, Exner F, Stroehle SP, Lutyj P, Tamihardja J, Veldhoen S, Flentje M, Polat B (2020)
Non-rigid image registration of 4D-MRI data for improved delineation of moving tumors
BMC Med Imaging 20 1 DOI: 10.1186/s12880-020-00439-6

Breuer K, Weick S, Stroehle SP, Breuer FA, Kleine P, Veldhoen S, Richter A, Lapa C, Flentje M, Polat B (2020)
Feasibility of 4D T2*quantification in the lung with oxygen gas challenge in patients with non-small cell lung cancer
Phys Med 72 S.46-51 DOI: 10.1016/j.ejmp.2020.03.009

Hartrampf PE, Hänscheid H, Kertels O, Schirbel A, Kreissl MC, Flentje M, Sweeney RA, Buck AK, Polat B, Lapa C (2020)
Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Clin Transl Radiat Oncol 22 S.29-32 DOI: 10.1016/j.ctro.2020.03.002

Martin D, Balermpas P, Gollrad J, Weiß C, Valentini C, Stuschke M, Schäfer H, Henckenberens C, Debus J, Krug D, Kuhnt T, Brunner T, Bostel T, Engenhart-Cabillic R, Nestle U, Combs S, Belka C, Hautmann M, Hildebrandt G, Gani C, Polat B, Rödel C, Fokas E (2020)
RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial.
Clin Transl Radiat Oncol 23 S.43-49 DOI: 10.1016/j.ctro.2020.04.010

Nieder C, Hess S, Lewitzki V (2020)
External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
Oncology Research and Treatment 43 5 S.221-227 DOI: 10.1159/000506954

Prieto-Garcia C, Hartmann O, Reissland M, Braun F, Fischer T, Walz S, Schülein-Völk C, Eilers U, Ade CP, Calzado MA, Orian A, Maric HM, Münch C, Rosenfeldt M, Eilers M, Diefenbacher ME (2020)
Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.
EMBO Mol Med 12 4 DOI: 10.15252/emmm.201911101

Richter JAJ, Wech T, Weng AM, Stich M, Weick S, Breuer K, Bley TA, Koestler H (2020)
Free-breathing self-gated 4D lung MRI using wave-CAIPI.
Magn Reson Med 84 6 S.3223-3233 DOI: 10.1002/mrm.28383

Fernandez C, Grills IS, Ye H, Hope AJ, Guckenberger M, Mantel F, Kestin LL, Belderbos J, Werner-Wasik M (2020)
Stereotactic Image Guided Lung Radiation Therapy for Clinical Early Stage Non-Small Cell Lung Cancer: A Long-Term Report From a Multi-Institutional Database of Patients Treated With or Without a Pathologic Diagnosis.
Pract Radiat Oncol 10 4 S.e227-e237 DOI: 10.1016/j.prro.2019.12.003

Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, Blanck O, Dieckmann K, Eich HT, Mantel F, Eble M, Hope A, Grosu AL, Nevinny-Stickel M, Semrau S, Sweeney RA, Hörner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Grills I, Guckenberger M (2020)
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments.
Int J Radiat Oncol Biol Phys 107 3 S.579-586 DOI: 10.1016/j.ijrobp.2020.03.005

Meyer TJ, Scherzad A, Moratin H, Gehrke TE, Killisperger J, Hagen R, Wohlleben G, Polat B, Dembski S, Kleinsasser N, Hackenberg S (2019)
The Radiosensitizing Effect of Zinc Oxide Nanoparticles in Sub-Cytotoxic Dosing Is Associated with Oxidative Stress In Vitro.
Materials 12 24 DOI: 10.3390/ma12244062

Djuzenova CS, Fiedler V, Memmel S, Katzer A, Sisario D, Brosch PK, Göhrung A, Frister S, Zimmermann H, Flentje M, Sukhorukov VL (2019)
Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
BMC Cancer 19 1 DOI: 10.1186/s12885-019-5517-4

Bettinger D, Pinato DJ, Schultheiss M, Sharma R, Rimassa L, Pressiani T, Burlone ME, Pirisi M, Kudo M, Park JW, Buettner N, Neumann-Haefelin C, Boettler T, Abbasi-Senger N, Alheit H, Baus W, Blanck O, Gerum S, Guckenberger M, Habermehl D, Ostheimer C, Riesterer O, Tamihardja J, Grosu AL, Thimme R, Brunner TB, Gkika E (2019)
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.
Liver Cancer 8 4 S.281-294 DOI: 10.1159/000490260

Mantel F, Sweeney RA, Klement RJ, Hawkins MA, Belderbos J, Ahmed M, Toussaint A, Polat B, Flentje M, Guckenberger M (2019)
Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study.
Radiother Oncol 141 S.62-66 DOI: 10.1016/j.radonc.2019.08.026

Klement RJ, Abbasi-Senger N, Adebahr S, Alheid H, Allgaeuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Eble MJ, Ernst I, Gerum S, Habermehl D, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lewitzki V, Lohaus F, Ostheimer C, Papachristofilou A, Petersen C, Rieber J, Schneider T, Schrade E, Semrau R, Wachter S, Wittig A, Guckenberger M, Andratschke N (2019)
The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
BMC Cancer 19 1 S.173 DOI: 10.1186/s12885-019-5362-5

Foerster R, Cho BCJ, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad MS, Kersh CR, Létourneau D, Mantel F, Sahgal A, Shin JH, Winey BA, Guckenberger M (2019)
Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study.
Neurosurgery 84 2 S.435-441 DOI: 10.1093/neuros/nyy059

Selvaraj J, Lebesque J, Hope A, Guckenberger M, Werner-Wasik M, Peulen H, Giuliani M, Mantel F, Belderbos J, Grills I, Sonke JJ (2019)
Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.
Radiother Oncol 132 S.142-147 DOI: 10.1016/j.radonc.2018.12.015

Stam B, Kwint M, Guckenberger M, Mantel F, Hope A, Giuliani M, Werner-Wasik M, Grills I, Sonke JJ, Belderbos J (2019)
Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.
Int J Radiat Oncol Biol Phys 103 1 S.132-141 DOI: 10.1016/j.ijrobp.2018.08.040

Wegener S, Weick S, Sauer OA (2019)
Influence of a transverse magnetic field on the response of different detectors in a high energy photon beam near the surface.
Z Med Phys 29 1 S.22-30 DOI: 10.1016/j.zemedi.2018.07.001

Richter A, Exner F, Bratengeier K, Polat B, Flentje M, Weick S (2019)
Impact of beam configuration on VMAT plan quality for Pinnacle3Auto-Planning for head and neck cases.
Radiat Oncol 14 1 DOI: 10.1186/s13014-019-1211-6

Lewitzki V, Klement RJ, Kosmala R, Lisowski D, Flentje M, Polat B (2019)
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Radiat Oncol 14 1 DOI: 10.1186/s13014-019-1427-5

Greber J, Polat B, Flentje M, Bratengeier K (2019)
Properties of the anisotropy of dose contributions: A planning study on prostate cases.
Med Phys 46 2 S.419-425 DOI: 10.1002/mp.13308

Rades D, Šegedin B, Conde-Moreno AJ, Ferrer-Albiach C, Metz M, Polat B, Badakhshi H, Schreiber A, Nitsche M, Cacicedo J, Schild SE (2019)
Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression.
Int J Radiat Oncol Biol Phys 105 4 S.760-764 DOI: 10.1016/j.ijrobp.2019.08.002

Bratengeier K, Holubyev K, Wegener S (2019)
Steeper dose gradients resulting from reduced source to target distance-a planning system independent study.
J Appl Clin Med Phys 20 1 S.89-100 DOI: 10.1002/acm2.12490

Brunner TB, Blanck O, Lewitzki V, Abbasi-Senger N, Momm F, Riesterer O, Duma MN, Wachter S, Baus W, Gerum S, Guckenberger M, Gkika E (2019)
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Radiother Oncol 132 S.42-47 DOI: 10.1016/j.radonc.2018.11.015

Tamihardja J, Zenk M, Flentje M (2019)
MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer.
Strahlenther Onkol 195 2 S.145-152 DOI: 10.1007/s00066-018-1364-5

Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST, Denzel J, Guo P, Bernhardt F, Schildmann E, van Oorschot B, Hodiamont F, Streitwieser S, Higginson IJ, Bausewein C (2019)
A brief, patient- and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS).
Palliat Med 33 8 S.1045-1057 DOI: 10.1177/0269216319854264

Fels J, Pigorsch S, Vorwerk H, Engenhart-Cabillic R, van Oorschot B (2019)
Palliative care in everyday practice of radiation oncologists : Results from a web-based survey among medical members of the German Society for Radiation Oncology (DEGRO).
Strahlenther Onkol 195 7 S.659-667 DOI: 10.1007/s00066-018-1403-2

Kuon J, Vogt J, Mehnert A, Alt-Epping B, van Oorschot B, Sistermanns J, Ahlborn M, Ritterbusch U, Stevens S, Kahl C, Ruellan A, Matthias K, Kubin T, Stahlhut K, Heider A, Lordick F, Thomas M, on behalf of the Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG) (2019)
Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment.
Oncology Research and Treatment 42 12 S.650-659 DOI: 10.1159/000502751

van Oorschot B, Mücke K, Cirak A, Henking T, Neuderth S (2019)
Desired place of death, living will and desired care at end of life: initial results of a survey of nursing home residents.
Z Gerontol Geriatr 52 6 S.582-588 DOI: 10.1007/s00391-018-1432-6

Wegener S, Sauer OA (2019)
The effective point of measurement for depth-dose measurements in small MV photon beams with different detectors.
Med Phys 46 11 S.5209-5215 DOI: 10.1002/mp.13788]

Roch C, van Oorschot B (2019)
Algorithm for cancer pain management
Onkologe 25 4 S.358-364 DOI: 10.1007/s00761-018-0500-2

van Oorschot B (2019)
Boundaries between curative and palliative medicine Rights of the patient and obligations of the physician
Onkologe 25 Suppl 1 S.90-95 DOI: 10.1007/s00761-019-0607-0

Kraywinkel K, van Oorschot B (2019)
Changes in survival rates and tumor characteristics with increasing age: results from population-based cancer registries
Onkologe 25 9 S.741-747 DOI: 10.1007/s00761-019-0639-5

van Oorschot B (2019)
Against: Does a geriatric Risk Assessment improve the Treatment Decision?
Onkologe 25 9 S.750-752 DOI: 10.1007/s00761-019-0572-7

van Oorschot B, Hartmannsgruber J (2019)
Documentation of frailty in aged patients in radio-oncology
Onkologe 25 9 S.768-775 DOI: 10.1007/s00761-019-0586-1

van Oorschot B, Schendzielorz P, Lewitzki V, Hackenberg S (2019)
Special aspects of palliative care for patients with head and neck cancer
Onkologe 25 3 S.262-268 DOI: 10.1007/s00761-019-0524-2

Pigorsch SU, Lewitzki V (2019)
Special features of radiotherapy in older patients with head and neck cancer
Onkologe 25 9 S.784-795 DOI: 10.1007/s00761-019-0588-z

Grimmig T, Gasser M, Moench R, Zhu LJ, Nawalaniec K, Callies S, Wagner M, Polat B, Mothi SS, Luo Y, Ribas CM, Malafaia O, Hsiao LL, Waaga-Gasser AM (2019)
Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects.
Oncoimmunology 8 12 DOI: 10.1080/2162402X.2019.1651622

Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schleska-Lange A, Flentje M, Gruetzmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Roedel C, German Rectal Canc Study Grp (2019)
Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial
Strahlenther Onkol 195 S.S40-S40

Kowatari M, Yoshitomi H, Nishino S, Tanimura Y, Ohishi T, Kessler P, Neumaier S, Röttger A (2019)
ESTABLISHMENT OF A LOW DOSE RATE GAMMA RAY CALIBRATION FIELD FOR ENVIRONMENTAL RADIATION MONITORING DEVICES.
Radiat Prot Dosimetry 187 1 S.61-68 DOI: 10.1093/rpd/ncz138

Kowatari M, Yoshitomi H, Nishino S, Tanimura Y, Ohishi T, Kessler P, Neumaier S, Röttger A (2019)
Establishment of a low dose rate gamma ray calibration field for environmental radiation monitoring devices.
Radiat Prot Dosimetry 186 4 S.538-538 DOI: 10.1093/rpd/ncz164

Jentschke E (2019)
Special features of palliative care in the old cancer patient
Onkologe 25 9 S.811-818 DOI: 10.1007/s00761-019-0642-x

Zetzl T, Schuler M, Renner A, Jentschke E, van Oorschot B (2019)
Yoga intervention and reminder e-mails for reducing cancer-related fatigue - a study protocol of a randomized controlled trial.
BMC Psychol 7 1 DOI: 10.1186/s40359-019-0339-3

Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grützmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rödel C, German Rectal Cancer Study Group (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
J Clin Oncol 37 34 S.3212-3222 DOI: 10.1200/JCO.19.00308

Beyer F, Vogt J, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, Dieterich M, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F, German Canc Soc DKG (2018)
Individual quality of life (SEIQoL) of cancer patients at diagnosis of incurability and during the course of cancer treatment - a prospective longitudinal multicenter cohort study of the Arbeitsgemeinschaft Palliativmedizin (APM)
Oncology Research and Treatment 41 S.260-260

van Oorschot B, Hoeller U, Ottstadt M, Schulze W, Pigorsch S, Riesenbeck D, Feyer P (2018)
Update: palliative radiotherapy of bone metastases. Recommendations of the German S3 guidelines on supportive therapy for cancer patients
Onkologe 24 3 S.253-258 DOI: 10.1007/s00761-018-0347-6

Müller AC, van Oorschot B, Micke O, Guckenberger M (2018)
German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist.
Strahlenther Onkol 194 1 S.1-8 DOI: 10.1007/s00066-017-1185-y

Sisario D, Memmel S, Doose S, Neubauer J, Zimmermann H, Flentje M, Djuzenova CS, Sauer M, Sukhorukov VL (2018)
Nanostructure of DNA repair foci revealed by superresolution microscopy.
FASEB J 32 12 S.6469-6477 DOI: 10.1096/fj.201701435

Klement RJ, Hoerner-Rieber J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Eich HC, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl KH, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Guckenberger M (2018)
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy.
Radiother Oncol 127 2 S.246-252 DOI: 10.1016/j.radonc.2018.02.016

Guckenberger M, Sweeney RA, Hawkins M, Belderbos J, Andratschke N, Ahmed M, Madani I, Mantel F, Steigerwald S, Flentje M (2018)
Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
Cancer 124 9 S.2001-2009 DOI: 10.1002/cncr.31294

Schäfer R, Strnad V, Polgár C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Gall C, Polat B, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) (2018)
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
Lancet Oncol 19 6 S.834-844 DOI: 10.1016/S1470-2045(18)30195-5

Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, Gutzmer R, Utikal JS, Goldinger SM, Geier M, Hassel JC, Balermpas P, Kiecker F, Rauschenberg R, Dietrich U, Clemens P, Berking C, Grabenbauer G, Schadendorf D, Grabbe S, Schuler G, Fietkau R, Distel LV, Heinzerling L (2018)
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
Br J Cancer 118 6 S.785-792 DOI: 10.1038/bjc.2017.489

Andratschke N, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement RJ, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D (2018)
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
BMC Cancer 18 1 S.283 DOI: 10.1186/s12885-018-4191-2

Wegener S, Sauer OA (2018)
Electrometer offset current due to scattered radiation.
J Appl Clin Med Phys 19 6 S.274-281 DOI: 10.1002/acm2.12458

Wohlleben G, Hauff K, Gasser M, Waaga-Gasser AM, Grimmig T, Flentje M, Polat B (2018)
Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
Oncol Rep 39 1 S.442-448 DOI: 10.3892/or.2017.6068

Rades D, Conde-Moreno AJ, Cacicedo J, Segedin B, Stanic K, Metz M, Rudat V, Schild SE (2018)
Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial.
Anticancer Res 38 2 S.1009-1015 DOI: 10.21873/anticanres.12316

Wegener S, Sauer OA (2018)
Energy response corrections for profile measurements using a combination of different detector types.
Med Phys 45 2 S.898-907 DOI: 10.1002/mp.12706

Breuer K, Meyer CB, Breuer FA, Richter A, Exner F, Weng AM, Ströhle S, Polat B, Jakob PM, Sauer OA, Flentje M, Weick S (2018)
Stable and efficient retrospective 4D-MRI using non-uniformly distributed quasi-random numbers.
Phys Med Biol 63 7 S.075002 DOI: 10.1088/1361-6560/aab342

Dietz A, Wichmann G, Kuhnt T, Pfreundner L, Hagen R, Scheich M, Kölbl O, Hautmann MG, Strutz J, Schreiber F, Bockmühl U, Schilling V, Feyer P, de Wit M, Maschmeyer G, Jungehülsing M, Schroeder U, Wollenberg B, Sittel C, Münter M, Lenarz T, Klussmann JP, Guntinas-Lichius O, Rudack C, Eich HT, Foerg T, Preyer S, Westhofen M, Welkoborsky HJ, Esser D, Thurnher D, Remmert S, Sudhoff H, Görner M, Bünzel J, Budach V, Held S, Knödler M, Lordick F, Wiegand S, Vogel K, Boehm A, Flentje M, Keilholz U (2018)
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol 29 10 S.2105-2114 DOI: 10.1093/annonc/mdy332

Gehrke T, Hackenberg S, Polat B, Wohlleben G, Hagen R, Kleinsasser N, Scherzad A (2018)
Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro.
Oncol Rep 39 4 S.1991-1998 DOI: 10.3892/or.2018.6267

Holzhaeuser E, van Oorschot B, Rades D (2018)
External-beamradiotherapy for pain control in patients with bone metastases.
Onkologe 24 11 S.902-909 DOI: 10.1007/s00761-018-0402-3

Mai SS, Goebel S, Jentschke E, van Oorschot B, Renner KH, Weber M (2018)
Feasibility, acceptability and adaption of dignity therapy: a mixed methods study achieving 360° feedback.
BMC Palliat Care 17 1 DOI: 10.1186/s12904-018-0326-0

van Oorschot B (2018)
Early integrated palliative care in cancer patients improves quality of life and encourages discussions about preferences for care at the end of life.
Strahlenther Onkol 194 2 S.178-180 DOI: 10.1007/s00066-017-1244-4

Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Lax S, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S (2018)
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.
Geburtsh Frauenheilk 78 11 S.1089-1109 DOI: 10.1055/a-0715-2964

Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, Ortmann O, Aretz S, Mallmann P, Kurzeder C, Hagen V, van Oorschot B, Höcht S, Feyer P, Egerer G, Friedrich M, Cremer W, Prott FJ, Horn LC, Prömpeler H, Langrehr J, Leinung S, Beckmann MW, Kimmig R, Letsch A, Reinhardt M, Alt-Epping B, Kiesel L, Menke J, Gebhardt M, Steinke-Lange V, Rahner N, Lichtenegger W, Zeimet A, Hanf V, Weis J, Mueller M, Henscher U, Schmutzler RK, Meindl A, Hilpert F, Panke JE, Strnad V, Niehues C, Dauelsberg T, Niehoff P, Mayr D, Grab D, Kreißl M, Witteler R, Schorsch A, Mustea A, Petru E, Hübner J, Rose AD, Wight E, Tholen R, Bauerschmitz GJ, Fleisch M, Juhasz-Boess I, Sigurd L, Runnebaum I, Tempfer C, Nothacker MJ, Blödt S, Follmann M, Langer T, Raatz H, Wesselmann S, Erdogan S (2018)
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.
Geburtsh Frauenheilk 78 10 S.949-971 DOI: 10.1055/a-0713-1218

Lewitzki V, Hess S, Nieder C, Flentje M (2018)
Validation of a prognostic score for patients with brain metastases based on extracranial factors.
Radiother Oncol 127 S.S365-S366 DOI: 10.1016/S0167-8140(18)31025-9

Vogt J, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, Dieterich M, Heider A, Loquai C, Stahlhut K, Ruellan A, Kubin TW, Dietz A, Oechsle K, Mehnert A, van Oorschot B, Thomas M, Ortmann O, Lordick F (2018)
Symptoms and palliative care needs of cancer patients at diagnosis of incurability - a pospective longitudinal multicenter cohort study of the Arbeitsgemeinschaft Palliativmedizin (APM)
Oncology Research and Treatment 41 S.21-22

Tienken M, Vogt J, Kahl C, Stahlhut K, Stevens S, Ahlborn M, Sistermanns J, Heider A, Kubin TW, Oechsle K, Ruellan A, Obst G, Alt-Epping B, Mehnert A, Thomas M, van Oorschot B, Lordick F (2018)
Assessment of disease burden and palliative care needs of patients with incurable gastrointestinal cancer-from the Arbeitsgemeinschaft Palliativmedizin (APM) palliative care project
Oncology Research and Treatment 41 S.134-134

Razinskas G, Wegener S, Greber J, Sauer OA (2018)
Sensitivity of the IQM transmission detector to errors of VMAT plans.
Med Phys 45 12 S.5622-5630 DOI: 10.1002/mp.13228

van Oorschot B, Fels J, Pigorsch S, Ottstadt M, Vorwerk H, AG Palliative Strahlentherapie (2018)
Palliative Medical Treatment in radiotherapeutic Everyday Life - first Results of a Survey of the medical DEGRO-Members
Strahlenther Onkol 194 S.S26-S27

Foerster R, Cho BCJ, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad MS, Kersh CR, Letourneau D, Mantel F, Sahgal A, Shin JH, Winey BA, Guckenberger M (2018)
Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT
Radiother Oncol 127 S.S441-S442 DOI: 10.1016/S0167-8140(18)31155-1

Guckenberger M, Klement R, Rieber J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Eich HT, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A (2018)
Repeat sbrt for pulmonary oligo-metastases
Radiother Oncol 127 S.S19-S19 DOI: 10.1016/S0167-8140(18)30354-2

Hoerner-Rieber J, Abbasi-Senger N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Eich HT, Flentje M, Gerum S, Haas P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Petersen C, Sackerer I, Schrade E, Uhlmann L, Wittig A, Guckenberger M (2018)
Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases
Radiother Oncol 127 S.S18-S19

Memmel S, Eing L, Sukhorukov VL, Flentje M, Djuzenova CS (2018)
Modified single-cell tracking approach for the assessment of individual tumor cells
Strahlenther Onkol 194 S.S166-S167

Polat B, Feuerbach I, Kerscher A, Wiegering A, Flentje M (2018)
Radiotherapy for the primary tumor in metastatic rectal cancer
Radiother Oncol 127 S.S808-S808 DOI: 10.1016/S0167-8140(18)31799-7

Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez CG, Slampa P, Allgaeuer M, Loessl K, Kovacs G, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Gall C, Polat B (2018)
QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial
Radiother Oncol 127 S.S173-S174 DOI: 10.1016/S0167-8140(18)30636-4

Guckenberger M, Sweeney R, Hawkins M, Belderbos J, Andratschke N, Ahmed M, Madani I, Mantel F, Steigerwald S, Flentje M (2018)
Stereotactic Body Radiation Therapy For Painful Spinal Metastases - Results Of A Phase 2 Study
Radiother Oncol 127 S.S244-S244 DOI: 10.1016/S0167-8140(18)30785-0

Schneebeli LSS, Alheid H, Allgaeuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M, Hildebrandt G, Klement R, Lewitzki V, Ostheimer C, Papacristofiou A, Petersen C, Schneider T, Semrau R, Wachter S, Habermehl D, Andratschke N (2018)
Influence of institutional Experience as well as the used Technology on the local Control and the Survival of Patients with Liver Metastases after SBRT
Strahlenther Onkol 194 S.S109-S109

Wack LJM, Sauer OA (2018)
The impact of isocenter movement on treatment plan delivery - a planning study
Radiother Oncol 127 S.S1071-S1071 DOI: 10.1016/S0167-8140(18)32278-3

Zenk M, Lewitzki V, Flentje M, Tamihardja J (2018)
MRI-assisted Identification of the dominant intraprostatic Lesion and dosimetric Analysis in the context of fluid-modulated Treatment Planning in primary Therapy of Prostate Cancer
Strahlenther Onkol 194 S.S155-S156

Forster R, Cho BCJ, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad MS, Kersh CR, Letourneau D, Mantel F, Sahgal A, Shin JH, Winey BA, Guckenberger M (2018)
Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT
Strahlenther Onkol 194 S.S181-S181

Gruhlich E, Stroehle SP, Weick S, Toussaint A, Flentje M, Polat B (2018)
Use of a simultaneous integrated Boost (SIB-IMRT) in the postoperative Irradiation of Prostate Cancer
Strahlenther Onkol 194 S.S92-S92

Hoerner-Rieber J, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Eich HT, Flentje M, Gerum S, Hass P, Henkenberens C, Herold HU, Hildebrandt G, Imhoff D, Janssen S, Kahl H, Klass ND, Krempien R, Lautenschlaeger SF, Lohaus F, Petersen C, Sackerer I, Schrade E, Uhlmann L, Wittig A, Guckenberger M (2018)
Pradictive Influence of different histological Subtypes on local Control after stereotactic Radiation (SBRT) of Lung Metastases in Patients with non-small cell Lung Cancer (NSCLC) in oligometastased Stage
Strahlenther Onkol 194 S.S67-S68

Kellner S, Bratengeier K, Exner F, Hess S, Flentje M, Lewitzki V (2018)
Clinical and dosimetric Analysis of own Results of cranial Stereotaxy without Compensation Filter
Strahlenther Onkol 194 S.S102-S102

Wegener S, Sauer OA (2018)
Consequences of the Influence of Scattered Radiation on internal Electrometers during Measurements with small-volume Ionization Chambers
Strahlenther Onkol 194 S.S149-S149

Hess S, Nieder C, Kellner S, Schaefer R, Flentje M, Lewitzki V (2018)
Radiotherapy of Brain Metastases: External Validation of the Prognosis Score of Nieder et al.
Strahlenther Onkol 194 S.S45-S45

Dietzsch S, Remmele J, Kitzing R, Timmermann B, Jablonska K, Vlad J, Schwarz R, Matuschek C, Grannass A, Lewitzki V, Valentini C, Rutkowski S, Kortmann RD (2018)
Deviations of the Risk Organ Contouring and its Influence on the documented Organ Doses in craniospinal Irradiation with Tumor Bed-Boost - Pilot Study from the SIOPE-PNET-5 MB-Protocol
Strahlenther Onkol 194 S.S34-S34

Moustakis C, Blanck O, Andratschke N, Boda-Heggemann J, Wilke L, Tanadini-Lang S, Albers D, Alraun M, Baeumer C, Beckers E, Blaschek M, Brunner T, Chan MKH, Dierl M, Droege S, Duma MN, Ebrahimi F, Eich HT, Fleckenstein J, Ganswindt U, Garbe S, Gkika E, Heinz C, Henkenberens C, Hennig A, Henning S, Koehn J, Kornhuber C, Kretschmer M, Krieger T, Loufti-Kraus B, Mayr M, Mensing T, Pfeiler T, Pollul G, Ramm U, Rieken S, Roeder F, Schmidthalter D, Schmitt D, Schoeffler J, Ulm C, Walke M, Weigel R, Wiehle R, Wiezorek T, Wolf U, Zimmer J, Baus W, Guckenberger M (2018)
Reference of Plan Comparison Study for Liver-SBRT - Results DEGRO AG/DGMP AK Stereotaxis
Strahlenther Onkol 194 S.S18-S19

Brunner T, Blanck O, Lewitzki V, Abbasi-Senger N, Momm F, Andratschke N, Habermehl D, Wachter S, Baus W, Gerum S, Guckenberger M, Gkika E (2018)
Dose of stereotactic radiotherapy, local control and overall survival in cholangiocarcinoma
Radiother Oncol 127 S.S85-S86 DOI: 10.1016/S0167-8140(18)30476-6

Ghadjar P, Hayoz S, Bernhard J, Zwahlen D, Stein J, Hoelscher T, Gut P, Polat B, Hildebrandt G, Mueller AC, Putora PM, Papachristofilou A, Schaer C, Pra AD, Rudolf CB, Wust P, Aebersold D, Thalmann G (2018)
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10
Oncology Research and Treatment 41 S.69-69

Peulen H, Sonke JJ, Van Werkhoven E, Werner-Wasik M, Grills I, Giuliani M, Hope A, Mantel F, Guckenberger M, Belderbos J (2018)
SBRT for peripheral lung tumors > 5 cm: first results of the multicenter phase I/II VOLUMES trial
Radiother Oncol 127 S.S17-S18 DOI: 10.1016/S0167-8140(18)30352-9

Levi JMH, van Limbergen E, Gal J, Schiappa R, Polgar C, Kauer-Dorner D, Pasquier D, Lemanski C, Deloge SR, Houvenaeghel G, Guix B, Belliere-Calandry A, Lossl K, Polat B, Gutierrez C, Galalae R, Strnad V (2018)
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis
Int J Radiat Oncol Biol Phys 102 3 S.S80-S80

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold DM, Thalmann GN, Swiss Group for Clinical Cancer Research (SAKK) (2018)
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.
Radiother Oncol 126 2 S.257-262 DOI: 10.1016/j.radonc.2017.10.025

Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Sedlmayer F, Wenz F, Zips D, Wiegel T, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (2018)
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Strahlenther Onkol 194 7 S.619-626 DOI: 10.1007/s00066-018-1269-3

Jentschke E, Thomas M, Babiak A, Lewerenz J, Oechsle K, van Oorschot B, AG Palliativmed Deutsch Compr (2018)
SOP - Acute Confusional State
Onkologe 24 1 S.55-59 DOI: 10.1007/s00761-018-0407-y

Hass HG, Seywald M, Wöckel A, Flentje M, Weigel M, Beckmann MW, Kunzmann V (2018)
Early and late toxicity and side effects with relevance for social medicine in patients with breast cancer - Time-dependent analysis of 5800 breast cancer patients
Oncology Research and Treatment 41 4 S.108-108

Hass HG, Seywald M, Wöckel A, Flentje M, Weigel M, Beckmann MW, Kunzmann V (2018)
Prognostic value of Ki67 labelling index in different subtypes of invasive breast cancer
Oncology Research and Treatment 41 4 S.160-160

Hass HG, Seywald M, Wöckel A, Flentje M, Weigel M, Beckmann MW, Kunzmann V (2018)
Clinical and histopathological differences between premenopausal and postmenopausal ER plus breast cancer
Oncology Research and Treatment 41 4 S.298-298

Ostgathe C, Stachura P, Hofmann S, van Oorschot B, Oechsle K, Bogdan C, Kunz B, Foertsch B, Klein C (2018)
SOP - Handling of multidrug-resistant Pathogens in the Palliative Care Unit
Onkologe 24 S 1 S.75-81 DOI: 10.1007/s00761-018-0409-9

Grabenbauer F, Katzer A, Sisario D, Memmel S, Flentje M, Sukhorukov VL, Djuzenova CS (2018)
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.
Oncotarget 9 100 S.37379-37392 DOI: 10.18632/oncotarget.26436

Bartmann C, Janaki Raman SR, Flöter J, Schulze A, Bahlke K, Willingstorfer J, Strunz M, Wöckel A, Klement RJ, Kapp M, Djuzenova CS, Otto C, Kämmerer U (2018)
Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation.
Cancer Metab 6 S.8 DOI: 10.1186/s40170-018-0180-9

Spickermann H, Wegener S, Sauer OA (2018)
Evaluation of the reconstructed dose from the three-dimensional dose module of a helical diode array: factors of influence and error detection.
Phys Med Biol 64 1 DOI: 10.1088/1361-6560/aaf485

Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) (2017)
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Lancet Oncol 18 2 S.259-268 DOI: 10.1016/S1470-2045(17)30011-6

Ghadjar P, Hayoz S, Genitsch V, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Putora MP, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold DM, Thalmann GN, Swiss Group for Clinical Cancer Research (SAKK) (2017)
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.
BJU Int 120 5B S.E45-E51 DOI: 10.1111/bju.13742

Höcht S, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Hölscher T, Martin T, Sedlmayer F, Wenz F, Zips D, Wiegel T (2017)
Hypofractionated radiotherapy for localized prostate cancer.
Strahlenther Onkol 193 1 S.1-12 DOI: 10.1007/s00066-016-1041-5

Sauer A, Li M, Holl-Wieden A, Pabst T, Neubauer H (2017)
Readout-segmented multi-shot diffusion-weighted MRI of the knee joint in patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J 15 1 S.73 DOI: 10.1186/s12969-017-0203-z

Neubauer H, Li M, Müller VR, Pabst T, Beer M (2017)
Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
Rofo 189 7 S.640-650 DOI: 10.1055/s-0043-108993

Rieber J, Abbassi-Senger N, Adebahr S, Andratschke N, Blanck O, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Lohr F, Petersen C, Schrade E, Streblow J, Uhlmann L, Wittig A, Sterzing F, Guckenberger M (2017)
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
Int J Radiat Oncol Biol Phys 98 3 S.511-520 DOI: 10.1016/j.ijrobp.2016.09.026

Tanadini-Lang S, Rieber J, Filippi AR, Fode MM, Streblow J, Adebahr S, Andratschke N, Blanck O, Boda-Heggemann J, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Petersen C, Schrade E, Wendt TG, Wittig A, Høyer M, Ricardi U, Sterzing F, Guckenberger M (2017)
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease.
Radiother Oncol 123 2 S.182-188 DOI: 10.1016/j.radonc.2017.01.003

Klement RJ, Guckenberger M, Alheid H, Allgäuer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Habermehl D, Hildebrandt G, Lewitzki V, Ostheimer C, Papachristofilou A, Petersen C, Schneider T, Semrau R, Wachter S, Andratschke N (2017)
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
Radiother Oncol 123 2 S.227-233 DOI: 10.1016/j.radonc.2017.01.013

Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Ka Heng Chan M, Ernst I, Krieger T, Duma MN, Oechsner M, Ganswindt U, Heinz C, Alheit H, Blank H, Nestle U, Wiehle R, Kornhuber C, Ostheimer C, Petersen C, Pollul G, Baus W, Altenstein G, Beckers E, Jurianz K, Sterzing F, Kretschmer M, Seegenschmiedt H, Maass T, Droege S, Wolf U, Schoeffler J, Haverkamp U, Eich HT, Guckenberger M (2017)
Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
Strahlenther Onkol 193 10 S.780-790 DOI: 10.1007/s00066-017-1151-8

Hoerner-Rieber J, Duma M, Blanck O, Hildebrandt G, Wittig A, Lohaus F, Flentje M, Mantel F, Krempien R, Eble MJ, Kahl KH, Boda-Heggemann J, Rieken S, Guckenberger M (2017)
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
J Thorac Dis 9 11 S.4512-4522 DOI: 10.21037/jtd.2017.10.108

Seekatz B, Lukasczik M, Löhr M, Ehrmann K, Schuler M, Keßler AF, Neuderth S, Ernestus RI, van Oorschot B (2017)
Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care.
Support Care Cancer 25 9 S.2761-2770 DOI: 10.1007/s00520-017-3687-7

Said HM, Safari R, Al-Kafaji G, Ernestus RI, Löhr M, Katzer A, Flentje M, Hagemann C (2017)
Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.
Oncol Rep 37 6 S.3625-3634 DOI: 10.3892/or.2017.5620

Polat B, Kaiser P, Wohlleben G, Gehrke T, Scherzad A, Scheich M, Malzahn U, Fischer T, Vordermark D, Flentje M (2017)
Perioperative changes in osteopontin and TGF?1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
BMC Cancer 17 1 S.6 DOI: 10.1186/s12885-016-3024-4

Sander B, Xu W, Eilers M, Popov N, Lorenz S (2017)
A conformational switch regulates the ubiquitin ligase HUWE1.
Elife 6 DOI: 10.7554/eLife.21036

Memmel S, Sisario D, Zöller C, Fiedler V, Katzer A, Heiden R, Becker N, Eing L, Ferreira FLR, Zimmermann H, Sauer M, Flentje M, Sukhorukov VL, Djuzenova CS (2017)
Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
Oncotarget 8 28 S.45298-45310 DOI: 10.18632/oncotarget.16847

Richter A, Weick S, Krieger T, Exner F, Kellner S, Polat B, Flentje M (2017)
Evaluation of a software module for adaptive treatment planning and re-irradiation.
Radiat Oncol 12 1 S.205 DOI: 10.1186/s13014-017-0943-4

Körner P, Ehrmann K, Hartmannsgruber J, Metz M, Steigerwald S, Flentje M, van Oorschot B (2017)
Patient-reported symptoms during radiotherapy : Clinically relevant symptom burden in patients treated with palliative and curative intent.
Strahlenther Onkol 193 7 S.570-577 DOI: 10.1007/s00066-017-1146-5

Janssen S, van Oorschot B, Käsmann L, Schild SE, Rades D (2017)
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer.
Anticancer Res 37 5 S.2537-2540 DOI: 10.21873/anticanres.11596

Bratengeier K, Herzog B, Wegener S, Holubyev K (2017)
Finer leaf resolution and steeper beam edges using a virtual isocentre in concurrence to PTV-shaped collimators in standard distance - a planning study.
Radiat Oncol 12 1 S.88 DOI: 10.1186/s13014-017-0826-8

Weick S, Völker M, Hemberger K, Meyer C, Ehses P, Polat B, Breuer FA, Blaimer M, Fink C, Schad LR, Sauer OA, Flentje M, Jakob PM (2017)
Desynchronization of Cartesian k-space sampling and periodic motion for improved retrospectively self-gated 3D lung MRI using quasi-random numbers.
Magn Reson Med 77 2 S.787-793 DOI: 10.1002/mrm.26159

Zimmermann MH, Beckmann G, Jung P, Flentje M (2017)
Hypopharyngeal and upper esophageal ulceration after cervical spine radiotherapy concurrent with crizotinib.
Strahlenther Onkol 193 7 S.589-592 DOI: 10.1007/s00066-017-1135-8

Rades D, Veninga T, Conde-Moreno AJ, Cacicedo J, Metz M, ?egedin B, Norkus D, Rudat V, Schild SE (2017)
Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression.
Pract Radiat Oncol 7 2 S.137-144 DOI: 10.1016/j.prro.2016.07.005

Rades D, Janssen S, Conde-Moreno AJ, Cacicedo J, Metz M, Veninga T, Segedin B, Rudat V, Schild SE (2017)
Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression.
J Med Imaging Radiat Oncol 61 3 S.388-393 DOI: 10.1111/1754-9485.12553

Casar B, Pasler M, Wegener S, Hoffman D, Talamonti C, Qian J, Mendez I, Brojan D, Perrin B, Kusters M, Canters R, Pallotta S, Peterlin P (2017)
Influence of the Integral Quality Monitor transmission detector on high energy photon beams: A multi-centre study.
Z Med Phys 27 3 S.232-242 DOI: 10.1016/j.zemedi.2016.10.001

Giuliani ME, Hope A, Mangona V, Guckenberger M, Mantel F, Peulen H, Sonke JJ, Belderbos J, Werner-Wasik M, Ye H, Grills IS (2017)
Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
Clin Lung Cancer 18 2 S.162-168 DOI: 10.1016/j.cllc.2016.10.006

Giuliani M, Hope A, Guckenberger M, Mantel F, Peulen H, Sonke JJ, Belderbos J, Werner-Wasik M, Ye H, Grills IS (2017)
Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
Int J Radiat Oncol Biol Phys 98 4 S.893-899 DOI: 10.1016/j.ijrobp.2017.01.019

Roesch J, Cho JBC, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad M, Kersh R, Létourneau D, Mantel F, Sahgal A, Shin JH, Winey B, Guckenberger M (2017)
Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
Radiat Oncol 12 1 S.153 DOI: 10.1186/s13014-017-0887-8

Stam B, Peulen H, Guckenberger M, Mantel F, Hope A, Werner-Wasik M, Belderbos J, Grills I, O'Connell N, Sonke JJ (2017)
Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients.
Radiother Oncol 123 3 S.370-375 DOI: 10.1016/j.radonc.2017.04.017

Wegener S, Sauer OA (2017)
Separation of scatter from small MV beams and its effect on detector response.
Med Phys 44 3 S.1139-1148 DOI: 10.1002/mp.12091

Yarahmadi M, Wegener S, Sauer OA (2017)
Energy and field size dependence of a silicon diode designed for small-field dosimetry.
Med Phys 44 5 S.1958-1964 DOI: 10.1002/mp.12195

Flentje M, Fischer T (2017)
Multimodal therapy of small cell lung cancer
Onkologe 23 5 S.360-365

Alt-Epping B, Seidel W, Vogt J, Mehnert A, Thomas M, van Oorschot B, Wolff H, Schliephake H, Canis M, Dröge LH, Nauck F, Lordick F, Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG) (2016)
Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study.
Oncol Res Treat 39(4):186-91.

Berendt J, Oechsle K, Thomas M, van Oorschot B, Schmitz A, Radbruch L, Simon ST, Gärtner J, Thuß-Patience P, Schuler US, Hense J, Gog C, Viehrig M, Mayer-Steinacker R, Stachura P, Stiel S, Ostgathe C (2016)
State of integration of palliative care at Comprehensive Cancer Centers funded by German Cancer Aid.
Dtsch Med Wochenschr 141(2):e16-23.

Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K (2016)
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
Clin Nucl Med 41(7):515-21.

Bratengeier K, Holubyev K (2016)
Anisotropy of dose contributions-An instrument to upgrade real time IMRT and VMAT adaptation?
Med Phys 43(11):5826.

Colvill E, Booth J, Nill S, Fast M, Bedford J, Oelfke U, Nakamura M, Poulsen P, Worm E, Hansen R, Ravkilde T, Scherman Rydhög J, Pommer T, Munck Af Rosenschold P, Lang S, Guckenberger M, Groh C, Herrmann C, Verellen D, Poels K, Wang L, Hadsell M, Sothmann T, Blanck O, Keall P (2016)
A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking.
Radiother Oncol 119(1):159-65.   

Djuzenova CS, Fiedler V, Katzer A, Michel K, Deckert S, Zimmermann H, Sukhorukov VL, Flentje M (2016)
Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.
Oncotarget 7(25):38191-38209.

Flentje M, Huber RM, Engel-Riedel W, Andreas S, Kollmeier J, Staar S, Dickgreber N, Vaissiere N, De Almeida C, Edlich B, Fietkau R (2016)
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
Strahlenther Onkol 192(4):216-22.

Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F (2016)
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.
Radiother Oncol 118(3):485-91.

Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, Flickinger JC, Shin JH, Fahim DK, Winey B, Oh K, John Cho BC, Létourneau D, Sheehan J, Sahgal A(2016)
Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
J Neurosurg Spine 25(5):646-653.

Jawad MS, Fahim DK, Gerszten PC, Flickinger JC, Sahgal A, Grills IS, Sheehan J, Kersh R, Shin J, Oh K, Mantel F, Guckenberger M, on behalf of the Elekta Spine Radiosurgery Research Consortium (2016)
Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
J Neurosurg Spine 24(6):928-36.

Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Flentje M, Ganswindt U, Hass P, Henkenberens C, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Schmitt V, Semrau S, Sterzing F, Streblow J, Wendt TG, Wittig A, Guckenberger M (2016)
Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.
Int J Radiat Oncol Biol Phys 94(4):841-9.

Klement RJ, Belderbos J, Grills I, Werner-Wasik M, Hope A, Giuliani M, Ye H, Sonke JJ, Peulen H, Guckenberger M (2016)
Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?
J Thorac Oncol 11(7):1132-9.

Li M, Dick A, Hassold N, Pabst T, Bley T, Köstler H, Neubauer H (2016)
CAIPIRINHA-accelerated T1w 3D-FLASH for small-bowel MR imaging in pediatric patients with Crohn's disease: assessment of image quality and diagnostic performance.
World J Pediatr 12(4):455-462.

Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, ?yczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Kortmann RD, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) (2016)
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.
Radiother Oncol 120(1):119-23.

Peulen H, Mantel F, Guckenberger M, Belderbos J, Werner-Wasik M, Hope A, Giuliani M, Grills I, Sonke JJ (2016)
Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys 96(1):134-41.

Rades D, ?egedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, Badakhshi H, Schreiber A, Nitsche M, Hipp P, Schulze W, Adamietz IA, Norkus D, Rudat V, Cacicedo J, Schild SE (2016)
Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01).
J Clin Oncol 34(6):597-602.

Richter A, Polat B, Lawrenz I, Weick S, Sauer O, Flentje M, Mantel F (2016)
Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer.
Radiat Oncol 11(1):147.

Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M (2016)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Lung Cancer 97:51-8.

Roesch J, Panje C, Sterzing F, Mantel F, Nestle U, Andratschke N, Guckenberger M (2016)
SBRT for centrally localized NSCLC - What is too central?
Radiat Oncol 11(1):157.

Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Wendt TG, Fietkau R, Hindemith M, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Malzer M, Uter W, Polgár C, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) (2016)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a ran.
Lancet 387(10015):229-38.    

Toussaint A, Richter A, Mantel F, Flickinger JC, Grills IS, Tyagi N, Sahgal A, Letourneau D, Sheehan JP, Schlesinger DJ, Gerszten PC, Guckenberger M (2016)
Variability in spine radiosurgery treatment planning - results of an international multi-institutional study.
Radiat Oncol 11:57.

Xu W, Taranets L, Popov N (2016)
Regulating Fbw7 on the road to cancer.
Semin Cancer Biol 36:62-70.

Bratengeier K, Holubyev K (2015)
Characteristics of non-coplanar IMRT in the presence of target-embedded organs at risk. Radiat Oncol 10:207.

Djuzenova CS, Fiedler V, Memmel S, Katzer A, Hartmann S, Krohne G, Zimmermann H, Scholz CJ, Polat B, Flentje M, Sukhorukov VL (2015)
Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.
Exp Cell Res 330(2):346-57.

Djuzenova CS, Zimmermann M, Katzer A, Fiedler V, Distel LV, Gasser M, Waaga-Gasser AM, Flentje M, Polat B (2015)
A prospective study on histone ?-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome.
BMC Cancer 15:856.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM (2015)
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
J Clin Oncol 33(35):4158-66.

Kroeber J, Wenger B, Schwegler M, Daniel C, Schmidt M, Djuzenova CS, Polat B, Flentje M, Fietkau R, Distel LV (2015)
Distinct increased outliers among 136 rectal cancer patients assessed by ?H2AX.
Radiat Oncol 10:36.

Kuger S, Flentje M, Djuzenova CS (2015)
Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
Radiat Oncol 10:214.

Lewitzki V, Andratschke N, Kuhnt T, Hildebrandt G (2015)
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib.
Radiat Oncol 10:29.

Li M, Winkler B, Pabst T, Bley T, Köstler H, Neubauer H (2015)
Fast MR Imaging of the Paediatric Abdomen with CAIPIRINHA-Accelerated T1w 3D FLASH and with High-Resolution T2w HASTE: A Study on Image Quality.
Gastroenterol Res Pract 2015:693654.

Peulen H, Belderbos J, Guckenberger M, Hope A, Grills I, van Herk M, Sonke JJ (2015)
Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy.
Radiother Oncol 114(3):361-6.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M (2015)
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Strahlenther Onkol 191(2):125-32.

Thibault I, Chang EL, Sheehan J, Ahluwalia MS, Guckenberger M, Sohn MJ, Ryu S, Foote M, Lo SS, Muacevic A, Soltys SG, Chao S, Gerszten P, Lis E, Yu E, Bilsky M, Fisher C, Schiff D, Fehlings MG, Ma L, Chang S, Chow E, Parelukar WR, Vogelbaum MA, Sahgal A (2015)
Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group.
Lancet Oncol 16(16):e595-603.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M (2015)
Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
Radiother Oncol 116(2):269-75.

Vaegler S, Stsepankou D, Hesser J, Sauer O (2015)
Incorporation of local dependent reliability information into the Prior Image Constrained Compressed Sensing (PICCS) reconstruction algorithm.
Z Med Phys 25(4):375-90.

Völker M, Ehses P, Weick S, Breuer FA, Blaimer M, Hintze C, Biederer J, Jakob PM (2015)
Free breathing 1H MRI of the human lung with an improved radial turbo spin-echo. MAGMA 28(3):227-38.

Wohlleben G, Scherzad A, Güttler A, Vordermark D, Kuger S, Flentje M, Polat B (2015)
Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.
Radiat Oncol 10:167.

Buder K, Müller PA, Beckmann G, Ugurel S, Bröcker EB, Becker JC (2014)
Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases.
Acta Derm Venereol 94(1):94-6.

Groh CM, Hubbard ME, Jones PF, Loadman PM, Periasamy N, Sleeman BD, Smye SW, Twelves CJ, Phillips RM (2014)
Mathematical and computational models of drug transport in tumours.
J R Soc Interface 11(94):20131173.

Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O, Deutschen Gesellschaft für Radioonkologie (DEGRO) (2014)
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.
Strahlenther Onkol 190(1):26-33.

Guckenberger M, Lawrenz I, Flentje M (2014)
Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.
Strahlenther Onkol 190(1):48-53.

Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Létourneau D, Grills IS, Jawad M, Fahim DK, Shin JH, Winey B, Sheehan J, Kersh R (2014)
Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.
Radiat Oncol 9:226.

Holubyev K, Gainey M, Bratengeier K, Polat B, Flentje M (2014)
Generation of prostate IMAT plans adaptable to the inter-fractional changes of patient geometry.
Phys Med Biol 59(8):1947-62.

Kestin L, Grills I, Guckenberger M, Belderbos J, Hope AJ, Werner-Wasik M, Sonke JJ, Bissonnette JP, Xiao Y, Yan D, Elekta Lung Research Group (2014)
Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
Radiother Oncol 110(3):499-504.

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M (2014)
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Int J Radiat Oncol Biol Phys 88(3):732-8.

Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M (2014)
Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
Strahlenther Onkol 190(6):521-32.

Mantel F, Glatz S, Toussaint A, Flentje M, Guckenberger M (2014)
Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.
Strahlenther Onkol 190(12):1141-8.

Memmel S, Sukhorukov VL, Höring M, Westerling K, Fiedler V, Katzer A, Krohne G, Flentje M, Djuzenova CS (2014)
Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.
PLoS ONE 9(1):e87052.

Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Glück A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO (2014)
Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
Strahlenther Onkol 190(4):377-81.

Serpa M, Baier K, Cremers F, Guckenberger M, Meyer J (2014)
Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy.
Med Phys 41(3):031702.

Sweeney R, Polat B, Samnick S, Reiners C, Flentje M, Verburg FA (2014)    
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Ann Nucl Med 28(2):154-62.

Vaegler S, Bratengeier K, Beckmann G, Flentje M (2014)
Conformal breast irradiation with the arm of the affected side parallel to the body.
Strahlenther Onkol 190(1):100-5.

van Oorschot B, Assenbrunner B, Schuler M, Beckmann G, Flentje M (2014)
Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.
Strahlenther Onkol 190(3):270-5.

Wiegering A, Isbert C, Dietz UA, Kunzmann V, Ackermann S, Kerscher A, Maeder U, Flentje M, Schlegel N, Reibetanz J, Germer CT, Klein I (2014)
Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.
BMC Cancer 14:816.

Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, Flentje M, Polat B (2013)
Radiosensitivity in breast cancer assessed by the histone ?-H2AX and 53BP1 foci.
Radiat Oncol 8:98.

Gerszten PC, Sahgal A, Sheehan JP, Kersh R, Chen S, Flickinger JC, Quader M, Fahim D, Grills I, Shin JH, Winey B, Oh K, Sweeney RA, Guckenberger M (2013)
A multi-national report on methods for institutional credentialing for spine radiosurgery.
Radiat Oncol 8:158.

Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N (2013)
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.
J Thorac Oncol 8(8):1050-8.

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M (2013)
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Radiother Oncol 109(1):13-20.

Guckenberger M, Klement RJ, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Xiao Y, Grills IS (2013)
Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Int J Radiat Oncol Biol Phys 85(4):1074-81.

Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M (2013)
Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Radiother Oncol 108(2):326-30.

Hahne JC, Meyer SR, Kranke P, Dietl J, Guckenberger M, Polat B, Hönig A (2013)
Studies on the role of osteopontin-1 in endometrial cancer cell lines.
Strahlenther Onkol 189(12):1040-8.

Hartmann S, Günther N, Biehl M, Katzer A, Kuger S, Worschech E, Sukhorukov VL, Krohne G, Zimmermann H, Flentje M, Djuzenova CS(2013)
Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines.
Cancer Lett 331(2):200-10.

Holubyev K, Bratengeier K, Gainey M, Polat B, Flentje M (2013)
Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases.
Radiat Oncol 8:263.

Kuger S, Graus D, Brendtke R, Günther N, Katzer A, Lutyj P, Polat B, Chatterjee M, Sukhorukov VL, Flentje M, Djuzenova CS (2013)
Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.
Translational oncology 6(2):169-79.

Mantel F, Flentje M, Guckenberger M (2013)
Stereotactic body radiation therapy in the re-irradiation situation--a review.
Radiat Oncol 8:7.

Müller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, Warmuth-Metz M, Voges J, Nikkhah G, Flentje M, Combs SE, Vordermark D, Kocher M, Kortmann RD (2013)
Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).
Strahlenther Onkol 189(8):647-55.

Polat B, Wohlleben G, Katzer A, Djuzenova CS, Technau A, Flentje M (2013)
Influence of osteopontin silencing on survival and migration of lung cancer cells.
Strahlenther Onkol 189(1):62-7.

Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT (2013)
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Bioorg Med Chem 21(13):3949-57.

Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P (2013)
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Int J Radiat Oncol Biol Phys 87(3):534-41.

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geißler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E, Guidelines Programme Oncology AWMF , German Cancer Society eV, German Cancer Aid (2013)
S3-guideline exocrine pancreatic cancer.
Z Gastroenterol 51(12):1395-440.

Steinmann D, Vordermark D, Geinitz H, Aschoff R, Bayerl A, Gerstein J, Hipp M, van Oorschot B, Wypior HJ, Schäfer C (2013)
Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.
Strahlenther Onkol 189(1):47-53.

Verburg FA, Sweeney R, Hänscheid H, Dießl S, Israel I, Löhr M, Vince GH, Flentje M, Reiners C, Samnick S (2013)
Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
Nuklearmedizin 52(1):36-42.

Wilbert J, Baier K, Hermann C, Flentje M, Guckenberger M (2013)
Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
Int J Radiat Oncol Biol Phys 85(1):237-42.

Yarahmadi M, Allahverdi M, Nedaie HA, Asnaashari K, Vaezzadeh SA, Sauer OA (2013)
Improvement of the penumbra for small radiosurgical fields using flattening filter free low megavoltage beams.
Z Med Phys 23(4):291-9.

Bratengeier K, Oechsner M, Gainey M (2012)
Methods for monitor-unit-preserving adaptation of intensity modulated arc therapy techniques to the daily target-A simple comparison.
Med Phys 39(2):713-20.

Bratengeier K, Seubert B, Holubyev K, Schachner H (2012)
Considerations on IMRT for quasi-isotropic non-coplanar irradiation.
Phys Med Biol 57(22):7303-15.

Djuzenova CS, Blassl C, Roloff K, Kuger S, Katzer A, Niewidok N, Günther N, Polat B, Sukhorukov VL, Flentje M (2012)
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
Cancer Biol Ther 13(6):425-34.

Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Belderbos J (2012)
A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.    
J Thorac Oncol 7(9):1382-93.

Guckenberger M, Alexandrow N, Flentje M (2012)
Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
Radiat Oncol 7:103.

Guckenberger M, Hawkins M, Flentje M, Sweeney RA. (2012)
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial.
BMC Cancer 12:530.

Guckenberger M, Kavanagh A, Partridge M (2012)
Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
Strahlenther Onkol 188(10):894-900.

Guckenberger M, Roesch J, Baier K, Sweeney RA, Flentje M (2012)
Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery.
Radiat Oncol 7:63.

Guckenberger M, Saur G, Wehner D, Sweeney RA, Thalheimer A, Germer CT, Flentje M (2012)
Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Strahlenther Onkol 188(7):551-7.

Hänscheid H, Sweeney RA, Flentje M, Buck AK, Löhr M, Samnick S, Kreissl M, Verburg FA (2012)
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
Eur J Nucl Med Mol Imaging 39(8):1284-8.

Hardcastle N, Tomé WA, Cannon DM, Brouwer CL, Wittendorp PW, Dogan N, Guckenberger M, Allaire S, Mallya Y, Kumar P, Oechsner M, Richter A, Song S, Myers M, Polat B, Bzdusek K (2012)
A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy.
Radiat Oncol 7:90.

Hintzsche H, Polat B, Schewe V, Djuzenova CS, Pfreundner L, Flentje M, Stopper H (2012)
Micronucleus formation kinetics in buccal mucosa cells of head and neck cancer patients undergoing radiotherapy.
Toxicol Lett 212(1):33-7.

Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, Boldt RG, Palma DA (2012)
Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.
Radiother Oncol 102(3):335-42.

Kreissl MC, Hänscheid H, Löhr M, Verburg FA, Schiller M, Lassmann M, Reiners C, Samnick SS, Buck AK, Flentje M, Sweeney RA (2012)
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Radiat Oncol 7:99.

Menten MJ, Guckenberger M, Herrmann C, Krauß A, Nill S, Oelfke U, Wilbert J (2012)
Comparison of a multileaf collimator tracking system and a robotic treatment couch tracking system for organ motion compensation during radiotherapy.
Med Phys 39(11):7032-41.

Neuhaus W, Burek M, Djuzenova CS, Thal SC, Koepsell H, Roewer N, Förster CY (2012)
Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells.
Neurosci Lett 506(1):44-9.

Niewidok N, Wack LJ, Schiessl S, Stingl L, Katzer A, Polat B, Sukhorukov VL, Flentje M, Djuzenova CS (2012)
Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity.
Translational oncology 5(5):356-69.

Ohri N, Werner-Wasik M, Grills IS, Belderbos J, Hope A, Yan D, Kestin LL, Guckenberger M, Sonke JJ, Bissonnette JP, Xiao Y (2012)
Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.    
Int J Radiat Oncol Biol Phys 84(3):e379-84.

Schmitt P, Jakob PM, Kotas M, Flentje M, Haase A, Griswold MA (2012)
T-one insensitive steady state imaging: a framework for purely T2-weighted TrueFISP.
Magn Reson Med 68(2):409-20.

Steinmann D, Paelecke-Habermann Y, Geinitz H, Aschoff R, Bayerl A, Bölling T, Bosch E, Bruns F, Eichenseder-Seiss U, Gerstein J, Gharbi N, Hagg J, Hipp M, Kleff I, Müller A, Schäfer C, Schleicher U, Sehlen S, Theodorou M, Wypior HJ, Zehentmayr F, van Oorschot B, Vordermark D (2012)
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
BMC Cancer 12:283.

Stingl L, Niewidok N, Müller N, Selle M, Djuzenova CS, Flentje M (2012)
Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90?.
Strahlenther Onkol 188(6):507-15.

Sweeney RA, Seubert B, Stark S, Homann V, Müller G, Flentje M, Guckenberger M (2012)
Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors.
Radiat Oncol 7:81.

van Oorschot B, Schuler M, Simon A, Flentje M (2012)
Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy.
Support Care Cancer 20(11):2729-36.